April 2014
Volume 55, Issue 13
Free
ARVO Annual Meeting Abstract  |   April 2014
Characterization of a refined mouse model of retinal vein occlusion
Author Affiliations & Notes
  • Andreas Ebneter
    Department of Ophthalmology, University of Bern, Bern, Switzerland
  • Cavit Agca
    Department of Ophthalmology, University of Bern, Bern, Switzerland
  • Sebastian Wolf
    Department of Ophthalmology, University of Bern, Bern, Switzerland
  • Volker Enzmann
    Department of Ophthalmology, University of Bern, Bern, Switzerland
  • Martin Sebastian Zinkernagel
    Department of Ophthalmology, University of Bern, Bern, Switzerland
  • Footnotes
    Commercial Relationships Andreas Ebneter, Novartis (I), Novartis (R); Cavit Agca, None; Sebastian Wolf, Allergan (C), Allergan (F), Allergan (R), Bayer (C), Bayer (F), Bayer (R), Euretina (S), Heidelberg Engineering (C), Heidelberg Engineering (F), Novartis (C), Novartis (F), Novartis (R), Optos (C), Optos (F), Optos (R); Volker Enzmann, None; Martin Zinkernagel, Allergan (F), Bayer (F), Heidelberg (C), Heidelberg (F), Novartis (C), Novartis (F), Novartis (I)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science April 2014, Vol.55, 6179. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Andreas Ebneter, Cavit Agca, Sebastian Wolf, Volker Enzmann, Martin Sebastian Zinkernagel; Characterization of a refined mouse model of retinal vein occlusion. Invest. Ophthalmol. Vis. Sci. 2014;55(13):6179.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract
 
Purpose
 

Retinal vein occlusion represents a chronic disorder of the inner retina with hypoxia, vascular leakage and neuronal degeneration causing significant morbidity. A reliable retinal vein occlusion model in mice would be a valuable tool for the investigation of specific questions regarding this disease using genetically modified animals. The aim of the current work was to refine and further characterize a model of retinal vein occlusion in mice.

 
Methods
 

Retinal vein occlusion was induced in BALB/c mice by indirect laser photocoagulation (532 nm) of 1-2 veins one disc diameter from the optic nerve after intravenous tail vein injection of Rose Bengal (25mg/kg), a photo-activator dye to enhance thrombus formation. Color fundus photographs (Optomap), retinal OCT imaging and fluorescein angiography using a 55° optic were performed at baseline, days 3, 7 and 14 after induction of the venous blockage. Mice were killed at various time-points and eyes processed for histology.

 
Results
 

Experimental retinal vein occlusion caused significant vascular change in the affected retina with remodeling of capillaries and shunt-vessel formation (Fig. 1). However, significant retinal thickening was not seen during the observational period using OCT imaging in this model with relatively mild laser. Nonetheless, retinal thinning (Fig. 2) was observed in the affected quadrant from day 7 onwards on OCT (p<0.001; one-way ANOVA for repeated measures). Imaging data corresponded well with findings on hematoxylin/eosin sections (Fig. 2).

 
Conclusions
 

Similar to the changes in humans suffering from retinal vein occlusion, experimental venous blockage induced shunt-vessel formation. Different intensities of laser application may mimic different severities of disease. However, some facets of human macular disease such as leakage and edema may not be appropriately represented due to structural differences. Further studies are needed to closer characterize this model, but the paradigm seems suitable to gain valuable insight into patho-mechanisms occurring during vascular remodeling after vein occlusion and other aspects of ischemic retinal disease.

 
 
Figure 1: Fluorescein angiography showing vascular remodeling 7 days after experimental retinal vein occlusion
 
Figure 1: Fluorescein angiography showing vascular remodeling 7 days after experimental retinal vein occlusion
 
 
Figure 2: Retinal thickness (95% CI) in the affected quadrant at different time-points after experimental retinal vein occlusion. H&E image shows degeneration of inner retinal layers 6 weeks after the insult
 
Figure 2: Retinal thickness (95% CI) in the affected quadrant at different time-points after experimental retinal vein occlusion. H&E image shows degeneration of inner retinal layers 6 weeks after the insult
 
Keywords: 637 pathology: experimental • 688 retina • 552 imaging methods (CT, FA, ICG, MRI, OCT, RTA, SLO, ultrasound)  
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×